Author

Winfried Amoaku

University of Nottingham, Queen’s Medical Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Adrian Bateman· 1 shared Ahmed Iqbal· 1 shared Ajoy BardhaniD· 1 shared Alexander Fleming· 1 shared Amira Zawia· 1 shared Amy P. Lynch· 1 shared Andrew V. Benest· 1 shared Ann AgeriD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adrian Bateman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement

Emma L. Short, ICCARP, Ian Michael Adcock, Bilal Al-Sarireh, Ann Ager, Ramzi Ajjan, Naveed Akbar, Michael A. Akeroyd, Ghada Alsaleh, Ghada Al-Sharbatee, Kambiz N. Alavian, Winfried Amoaku, Julie Andersen, Chrystalina A. Antoniades, Mark J. Arends, , Werner Kempf

The paper establishes international consensus criteria to classify ageing-related pathologies, diseases, and syndromes based on age progression, functional decline, and human evidence.

GeroScience · Sep 21, 2024Peer-reviewedGenetic & Genomic Medicine

The splicing factor kinase SRPK1 is a therapeutic target for Peripheral Vascular Disease

Sohni Ria Bhalla, Mussarat Wahid, Jason O. Amartey, Amira Zawia, Federica Riu, Yizhuo Gao, Jyoti Agrawal, Amy P. Lynch, Maria J. C. Machado, Tom Hawtrey, Ryosuke Kikuchi, Kathryn R. Green, Lydia Teboul, Claire Allen, Zoe Blackley, , David O. Bates

This paper shows that inhibiting SRPK1 in monocytes promotes angiogenesis by altering VEGF splicing from anti-angiogenic VEGF-A165b to pro-angiogenic VEGF-A165a in both human and mouse models of peripheral arterial disease.

bioRxiv · Apr 17, 2024Physiology